The best indicator for Bio-Techne (TECH)
We backtested 366 indicators across daily, weekly and hourly charts on real Bio-Techne (TECH) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
KAMA 200 Trend
On the weekly chart, this is the strongest risk-adjusted edge we found for Bio-Techne (TECH) over ~37.5 years — trailing buy-and-hold by 2.7% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Bio-Techne (TECH) — trailing buy-and-hold by 14.8% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | KAMA 200 Trend ✓ | Weekly | 15.8% | 0.65 | -59.9% | 41.9% | 31 | -2.7% |
| 2 | Projection Bands ✓ | Daily | 13.7% | 0.63 | -51.3% | 61.2% | 327 | -4.9% |
| 3 | Chande-Kroll Stop (fast) ✓ | Weekly | 16.1% | 0.61 | -74.1% | 48.1% | 108 | -2.3% |
| 4 | Markov Regime ✓ | Daily | 17.8% | 0.61 | -74.4% | 60.0% | 25 | -0.8% |
| 5 | VIDYA 200 Trend ✓ | Daily | 17.3% | 0.6 | -74.0% | 51.5% | 33 | -1.3% |
| 6 | Pivot Points (Standard) | Daily | 12.3% | 0.59 | -72.0% | 50.3% | 1194 | -6.3% |
| 7 | MA Ribbon ✓ | Weekly | 12.6% | 0.59 | -53.4% | 52.6% | 38 | -5.8% |
| 8 | DEMA 20/50 Cross ✓ | Weekly | 12.9% | 0.58 | -53.6% | 50.0% | 32 | -5.6% |
| 9 | Chandelier Exit ✓ | Weekly | 14.2% | 0.58 | -68.3% | 42.9% | 63 | -4.3% |
| 10 | SMA 5/20 Cross ✓ | Weekly | 13.7% | 0.58 | -65.7% | 49.1% | 55 | -4.7% |
| 11 | KAMA 100 Trend ✓ | Weekly | 12.8% | 0.58 | -63.8% | 43.6% | 55 | -5.7% |
| 12 | EMA 15/60 Cross ✓ | Weekly | 14.1% | 0.58 | -71.1% | 52.4% | 21 | -4.4% |
| 13 | SMA 10/40 Cross ✓ | Weekly | 13.6% | 0.58 | -64.5% | 69.0% | 29 | -4.9% |
| 14 | WMA 20/50 Cross ✓ | Weekly | 13.3% | 0.57 | -70.7% | 60.9% | 23 | -5.2% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Bio-Techne (TECH), KAMA 200 Trend on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.